Dr. Emilia Javorsky

Now, if we could use AI to help us find out cheaper ways to manufacture that, bring down the cost, be able to make the drug in more places closer to the patient, now way more patients can actually access this because it's no longer cost prohibitive.

So you can use AI in that way to democratize access through bringing down the costs of manufacturing a new drug.

Yeah, absolutely.

I mean, it's absurd to me, the situation that we're in, that there's so much we could be doing that we are not actually doing, and we're doing all of the wrong things, right?

And investing unprecedented sums of money into the wrong things.

Like, if we are actually serious—

thing we want to do with AI is to cure cancer, and the goal is curing cancer, we need to say, what is the fastest way to achieve that goal?

Where do we put our dollars to get that goal?

And there's so many places we could put our dollars that get us there a lot faster.

Yeah, I was just going to say, Tristan, I think there's like a framing to this in the conversation, which is a lot of what we're discussing is whether ASI or a different approach that is a more AI tools and systems redesign approach is the most effective way to cure cancer.

And that's just looking at the upside piece of it.

But there's also a requirement to complete the risk-benefit analysis and say, what are the benefits of these potential technologies, but also what are the risks?

And that's where you see a lot more divergence between these two perspectives, because we know there's a lot of systemic risks with ASI development, right?

With the tools and the system redesign approach, there aren't those risks, those systemic risks.

And so what you end up with is being able to sort of have your cake and eat it too, where you get the benefits of AI in progress without taking on the risks.

And I think this is a false choice we're forced to make quite often in the discourse.

It's like we either get our cancer cures and then we have to take on the risks of unemployment, extinction, X, Y, and Z. There's another path here where we get our cancer cures and we don't take that on, right?

Like there's a different option on the table that I think often kind of gets pushed aside.

Thank you, guys.